Existing dietary guidelines for Crohns disease and ulcerative colitis

Expert Review of Gastroenterology and Hepatology

Volumn 5, Issue 3, 2011, Pages 411-425

  Brown, Amy C ^a   Rampertab, S Devi ^b   Mullin, Gerard E ^c  

^a UNIVERSITY OF HAWAII   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Crohns disease; diet; dietary supplements; enteral nutrition; inflammatory bowel disease; nutrition; parenteral nutrition; ulcerative colitis

Indexed keywords

CORTICOSTEROID; FORTISON; NUTRACEUTICAL; UNCLASSIFIED DRUG; VIVONEX;

ABDOMINAL PAIN; CLINICAL PRACTICE; CROHN DISEASE; DIARRHEA; DIET SUPPLEMENTATION; DIETARY INTAKE; ENTERIC FEEDING; EVIDENCE BASED MEDICINE; FLATULENCE; FOOD INTAKE; GASTROENTEROLOGY; HUMAN; JAPANESE; LACTOSE INTOLERANCE; MEDICAL SOCIETY; NUTRITIONAL REQUIREMENT; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PRACTICE GUIDELINE; REVIEW; ULCERATIVE COLITIS; VITAMIN SUPPLEMENTATION;

COLITIS, ULCERATIVE; CROHN DISEASE; DIET; ENTERAL NUTRITION; EVIDENCE-BASED MEDICINE; HUMANS; PRACTICE GUIDELINES AS TOPIC; RECURRENCE; REMISSION INDUCTION; SOCIETIES, MEDICAL; TREATMENT OUTCOME;

EID: 79958271259     PISSN: 17474124     EISSN: 17474132     Source Type: Journal    
DOI: 10.1586/egh.11.29     Document Type: Review

References (85)

1. Brown AC, Roy M. Does evidence exist to include dietary therapy in the treatment of Crohns disease? Expert Rev. Gastroenterol. Hepatol. 4(2), 191-215 (2010).
2. Lichtenstein GR, Hanauer SB, Sandborn WJ; Practice Parameters Committee of American College of Gastroenterology. Management of Crohns disease in adults. Am. J. Gastroenterol. 104(2), 465-483 (2009).
3. Kornbluth A, Sachar DB; Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am. J. Gastroenterol. 105(3), 501-523 (2010).
4. Bernstein CN, Fried M, Krabshuis JH, et al. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm. Bowel Dis. 16(1), 112-124 (2010).
5. ASPEN Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J. Parenter. Enteral. Nutr. 26(1 Suppl.), SA1-SA138 (2002).
6. Lochs H, Dejong C, Hammarqvist F, et al. ESPEN guidelines on enteral nutrition: Gastroenterology. Clin. Nutr. 25, 260-274 (2006). (Pubitemid 43811680)
7. Van Gossum A, Cabre E, Hébuterne X et al. ESPEN Guidelines on Parenteral Nutrition: gastroenterology. Clin. Nutr. 28(4), 415-427 (2009).
8. Working Group of the Japanese Society for Pediatric Gastroenterology, Hepatology and Nutrition; Konno M, Kobayashi A et al. Guidelines for the treatment of Crohns disease in children. Pediatr. Int. 48(3), 349-352 (2006).
9. Vaisman N, Dotan I, Halack A, Niv E. Malabsorption is a major contributor to underweight in Crohns disease patients in remission. Nutrition 22(9), 855-859 (2006). (Pubitemid 44234012)
10. Yamamoto T, Nakahigashi M, Saniabadi AR. Review article: diet and inflammatory bowel disease - epidemiology and treatment. Aliment. Pharmacol. Ther. 30(2), 99-112 (2009).
11. Hartman C, Eliakim R, Shamir R. Nutritional status and nutritional therapy in inflammatory bowel diseases. World J. Gastroenterol. 15(21), 2570-2578 (2009).
12. Razack R, Seidner DL. Nutrition in inflammatory bowel disease. Curr. Opin. Gastroenterol. 23(4), 400-405 (2007). (Pubitemid 46878952)
13. Song HK, Buzby GP. Nutritional support for Crohns disease. Surg. Clin. North Am. 81(1), 103-115, viii (2001).
14. Rigaud D, Cerf M, Angel Alberto L, Sobhani I, Carduner MJ, Mignon M. [Increase of resting energy expenditure during flare-ups in Crohn disease]. Gastroenterol. Clin. Biol. 17(12), 932-937 (1993). (Pubitemid 24049208)
15. Heyman MB, Garnett EA, Wojcicki J, et al. Growth hormone treatment for growth failure in pediatric patients with Crohns disease. J. Pediatr. 153(5), 651-658 (2008).
16. Oldenburg B, Koningsberger JC, Van Berge Henegouwen GP, Van Asbeck BS, Marx JJ. Iron and inflammatory bowel disease. Aliment. Pharmacol. Ther. 15(4), 429-438 (2001).
17. Green TJ, Issenman RM, Jacobson K. Patients diets and preferences in a pediatric population with inflammatory bowel disease. Can. J. Gastroenterol. 12(8), 544-549 (1998). (Pubitemid 29048046)
18. Roy M. Dietary survey of Crohns disease patients in the state of Hawaii. University of Hawaii Thesis Project. 1-333 (2009).
19. Mishkin, S. Dairy sensitivity, lactose malabsorption, and elimination diets in inflammatory bowel disease. Am. J. Clin. Nutr. 65(2), 564-567 (1997).
20. Ballegaard M, Bjergstrøm A, Brøndum S et al. Self-reported food intolerance in chronic inflammatory bowel disease. Scand. J. Gastroenterol. 32(6), 569-571 (1997). (Pubitemid 27314267)
21. Guilford WG. Nutritonal management of gastrointestinal tract diseases of dogs and cats. J. Nutr. 124(12 Suppl.), S2663-S2669 (1994).
22. de Jong NS, Leach ST, Day AS. Polymeric formula has direct anti-inflammatory effects on enterocytes in an in vitro model of intestinal inflammation. Dig. Dis. Sci. 52(9), 2029-2036 (2007). (Pubitemid 47246499)
23. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohns disease. Cochrane Database Syst. Rev. CD000542 (2007).
24. Smith PA. Nutritional therapy for active Crohns disease. World J. Gastroenterol. 14(27), 4420-4423 (2009).
25. Dziechciarz P, Horvath A, Shamir R, Szajewska H. Meta-analysis: enteral nutrition in active Crohns disease in children. Aliment. Pharmacol. Ther. 26(6), 795-806 (2007). (Pubitemid 47346708)
26. Matsui T, Sakurai T, Yao T. Nutritional therapy for Crohns disease in Japan. J. Gastroenterol. 40(Suppl. 16), 25-31 (2005).
27. Akobeng AK, Richmond K, Miller V, et al. Effect of exclusive enteral nutritional treatment on plasma antioxidant concentrations in childhood Crohns disease. Clin. Nutr. 26(1), 51-56 (2007). (Pubitemid 46179126)
28. Yamamoto T, Nakahigashi M, Umegae S et al. Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohns disease: a prospective, non-randomized, parallel, controlled study. Aliment. Pharmacol. Ther. 25(1), 67-72 (2007). (Pubitemid 44902865)
29. Takagi S, Utsunomiya K, Kuriyama S, et al. Effectiveness of an half elemental diet as maintenance therapy for Crohns disease: a randomized- controlled trial. Aliment. Pharmacol. Ther. 24(9), 1333-1340 (2006). (Pubitemid 44571563)
30. Johnson T, Macdonald S, Hill SM, et al. Treatment of active Crohns disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial. Gut 55(3), 356-361 (2006). (Pubitemid 43268273)
31. Eivindson M, Grønbaek H, Nielsen JN et al. Insulin-like growth factors (IGFs) and IGF binding proteins in active Crohns disease treated with w-3 or w-6 fatty acids and corticosteroids. Scand. J. Gastroenterol. 40(10), 1214-1221 (2005). (Pubitemid 41510681)
32. Matsumoto T, Iida M, Kohgo Y, et al. Therapeutic efficacy of infliximab on active Crohns disease under nutritional therapy. Scand. J. Gastroenterol. 40(12), 1423-1430 (2005). (Pubitemid 43028203)
33. Ludvigsson JF, Krantz M, Bodin L et al. Elemental versus polymeric enteral nutrition in paediatric Crohns disease: a multicentre randomized controlled trial. Acta Paediatr. 93(3), 327-335 (2004). (Pubitemid 38316554)
34. Bamba T, Shimoyama T, Sasaki M, et al. Dietary fat attenuates the benefits of an elemental diet in active Crohns disease: a randomized, controlled trial. Eur. J. Gastroenterol. Hepatol. 15(2), 151-157 (2003). (Pubitemid 36269779)
35. Gassull MA, Fernández-Bañares F, Cabré E et al. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohns disease: results of a double blind randomized multicentre European trial. Gut 51(2), 164-168 (2002). (Pubitemid 34791440)
36. Sakurai T, Matsui T, Yao T, et al. Short-term efficacy of enteral nutrition in the treatment of active Crohns disease: a randomized, controlled trial comparing nutrient formulas. JPEN J. Parenter. Enteral. Nutr. 26(2), 98-103 (2002). (Pubitemid 34163552)
37. Verma S, Holdsworth CD, Giaffer MH. Does adjuvant nutritional support diminish steroid dependency in Crohn disease? Scand. J. Gastroenterol. 36(4), 383-388 (2001). (Pubitemid 32250734)
38. Verma S, Kirkwood B, Brown S, et al. Oral nutritional supplementation is effective in the maintenance of remission in Crohns disease. Dig. Liver Dis. 32(9), 769-774 (2000). (Pubitemid 32098074)
39. Fell JM, Paintin M, Arnaud-Battandier F et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohns disease. Aliment. Pharmacol. Ther. 14(3), 281-289 (2000). (Pubitemid 30145315)
40. Verma S, Brown S, Kirkwood B, et al. Polymeric versus elemental diet as primary treatment in active Crohns disease: a randomized, double-blind trial. Am. J. Gastroenterol. 95(3), 735-739 (2000). (Pubitemid 30123912)
41. Khoshoo V, Reifen R, Neuman MG, et al. Effect of low- and high-fat, peptide-based diets on body composition and disease activity in adolescents with active Crohns disease. JPEN J. Parenter. Enteral. Nutr. 20(6), 401-405 (1996). (Pubitemid 26399215)
42. Fukuda Y, Kosaka T, Okui M, et al. Efficacy of nutritional therapy for active Crohns disease. J. Gastroenterol. 30(Suppl. 8), 83-87 (1995).
43. Breese EJ, Michie CA, Nicholls SW et al. The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohns disease. Aliment. Pharmacol. Ther. 9(5), 547-552 (1995).
44. Israel DM, Hassall E. Prolonged use of gastrostomy for enteral hyperalimentation in children with Crohns disease. Am. J. Gastroenterol. 90(7), 1084-1088 (1995).
45. Royall D, Greenberg GR, Allard JP, et al. Total enteral nutrition support improves body composition of patients with active Crohns disease. JPEN J. Parenter. Enteral. Nutr. 19(2), 95-99 (1995).
46. Mansfield JC, Giaffer MH, Holdsworth CD. Controlled trial of oligopeptide versus amino acid diet in treatment of active Crohns disease. Gut 36(1), 60-66 (1995).
47. Ruuska T, Savilahti E, Mäki M, et al. Exclusive whole protein enteral diet versus prednisolone in the treatment of acute Crohns disease in children. J. Pediatr. Gastroenterol. Nutr. 19(2), 175-180 (1994). (Pubitemid 24299626)
48. Royall D, Jeejeebhoy KN, Baker JP, et al. Comparison of amino acid v peptide based enteral diets in active Crohns disease: clinical and nutritional outcome. Gut 35(6), 783-787 (1994).
49. González-Huix F, de León R, Fernández-Bañares F, et al. Polymeric enteral diets as primary treatment of active Crohns disease: a prospective steroid controlled trial. Gut 34(6), 778-782 (1993). (Pubitemid 23185103)
50. Hirakawa H, Fukuda Y, Tanida N, et al. Home elemental enteral hyperalimentation (HEEH) for the maintenance of remission in patients with Crohns disease. Gastroenterol. Jpn. 28(3), 379-384 (1993). (Pubitemid 23208894)
51. Rigaud D, Cosnes J, Le Quintrec Y, et al. Controlled trial comparing two types of enteral nutrition in treatment of active Crohns disease: elemental versus polymeric diet. Gut 32(12), 1492-1497 (1991).
52. Demetriou AA. Comparison of enteral nutrition and drug treatment in active Crohns disease: results of the European Cooperative Crohns Disease Study IV. JPEN J. Parenter. Enteral. Nutr. 16(1), 84-85 (1992).
53. Abad-Lacruz A, González-Huix F, Esteve M et al. Liver function tests abnormalities in patients with inflammatory bowel disease receiving artificial nutrition: a prospective randomized study of total enteral nutrition vs total parenteral nutrition. JPEN J. Parenter. Enteral. Nutr. 14(6), 618-621 (1990).
54. Giaffer MH, North G, Holdsworth CD. Controlled trial of polymeric versus elemental diet in treatment of active Crohns disease. Lancet 335(8693), 816-819 (1990). (Pubitemid 20113734)
55. Greenberg GR, Fleming CR, Jeejeebhoy KN, et al. Controlled trial of bowel rest and nutritional support in the management of Crohns disease. Gut 29(10), 1309-1315 (1998).
56. Belli DC, Seidman E, Bouthillier L, et al. Chronic intermittent elemental diet improves growth failure in children with Crohns disease. Gastroenterology 94(3), 603-610 (1998).
57. Akobeng AI, Clayton PE, Miller V, et al. Low serum concentrations of insulin-like growth factor-I in children with active Crohn disease: effect of enteral nutritional support and glutamine supplementation. Scand. J. Gastroenterol. 37(12), 1422-1427 (2002). (Pubitemid 36051503)
58. Akobeng AK, Miller V, Stanton J, et al. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohns disease. J. Pediatr. Gastroenterol. Nutr. 30(1), 78-84 (2000). (Pubitemid 30349950)
59. Schneeweiss B, Lochs H, Zauner C, et al. Energy and substrate metabolism in patients with active Crohns disease. J. Nutr. 129(4), 844-848 (1999). (Pubitemid 29162378)
60. Stolk MF, Van Erpecum KJ, Hiemstra G et al. Gallbladder motility and cholecystokinin release during long-term enteral nutrition in patients with Crohns disease. Scand. J. Gastroenterol. 29(10), 934-939 (1994). (Pubitemid 24315925)
61. Lochs H, Steinhardt HJ, Klaus-Wentz B et al. Comparison of enteral nutrition and drug treatment in active Crohns disease. Results of the European Cooperative Crohns Disease Study. IV. Gastroenterology 101(4), 881-888 (1991).
62. Axelsson C, Jarnum S. Assessment of the therapeutic value of an elemental diet in chronic inflammatory bowel disease. Scand. J. Gastroenterol. 12(1), 89-95 (1977). (Pubitemid 8031770)
63. Göschke H, Buess H, Gyr K, et al. [Elementary diet as an alternative to parenteral feeding in severe gastrointestinal diseases]. Schweiz. Med. Wochenschr. 107(2), 43-49 (1977). (Pubitemid 8014851)
64. OMorain C. Elemental diets in the treatment of Crohns disease. Proc. Nut. Soc. 38,403 (1979).
65. Breese EJ, Michie CA, Nicholls SW, et al. The effect of treatment on lymphokinesecreting cells in the intestinal mucosa of children with Crohns disease. Aliment. Pharmacol. Ther. 9, 547-552 (1995).
66. Fell JM, Paintin M, Arnaud-Battandier F et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohns disease. Aliment. Pharmacol. Ther. 14, 281-289 (2000). (Pubitemid 30145315)
67. Berni Canani R, Terrin G, Borrelli O, et al. Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohns disease. Dig. Liver Dis. 38, 381-387 (2006). (Pubitemid 44356207)
68. Borrelli O, Cordischi L, Cirulli M, et al. Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohns disease: a randomized controlled open-label trial. Clin. Gastroenterol. Hepatol. 4, 744-753 (2006). (Pubitemid 43825808)
69. Sanderson IR, Boulton P, Menzies I, Walker-Smith JA. Improvement of abnormal lactulose/rhamnose permeability in active Crohns disease of the small bowel by an elemental diet. Gut 28(9), 1073-1076 (1987). (Pubitemid 17154467)
70. Yamamoto T, Nakahigashi M, Umegae S, Kitagawa T, Matsumoto K. Impact of elemental diet on mucosal inflammation in patients with active Crohns disease: cytokine production and endoscopic and histological findings. Inflamm. Bowel Dis. 11(6), 580-588 (2005). (Pubitemid 40826346)
71. Winitz M, Adams RF, Seedman DA, Davis PN, Jayko LG, Hamilton JA. Studies in metabolic nutrition employing chemically defined diets. II. Effects on gut microflora populations. Am. J. Clin. Nutr. 23(5), 546-559 (1970).
72. Watanabe O, Ando T, Ishiguro K, Takahashi H, et al. Enteral nutrition decreases hospitalization rate in patients with Crohns disease. J. Gastroenterol. Hepatol. 25(1), S134-S137 (2010).
73. Harries AD, Jones LA, Danis V, et al. Controlled trial of supplemented oral nutrition in Crohns disease. Lancet 1(8330), 887-890 (1983). (Pubitemid 13112146)
74. Sanderson IR, Udeen S, Davies PS, Savage MO, Walker-Smith JA. Remission induced by an elemental diet in small bowel Crohns disease. Arch. Dis. Child. 62(2), 123-127 (1987). (Pubitemid 17004189)
75. Kleinman RE, Balistreri WF, Heyman MB et al. Nutritional support for pediatric patients with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 8(1), 8-12 (1989). (Pubitemid 19018720)
76. Shamir R. Nutritional aspects in inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 48(Suppl. 2), S86-S88 (2009).
77. Yamamoto T, Nakahigashi M, Saniabadi AR, et al. Impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal cytokines during remission in patients with Crohns disease: a prospective study. Inflamm. Bowel Dis. 13(12), 1493-1501 (2007).
78. Makola D. Elemental and semi-elemental formulas: are they superior to polymeric formulas? Pract. Gastroenterol. 24(12), 59-72 (2005).
79. American Dietetic Association www.eatright.org (Accessed 19 May 2011)
80. American Dietetic Association: Nutrition Care Manual www. nutritioncaremanual.org/auth. cfm?p=%2Findex%2Ecfm%3F (Accessed 19 May 2011)
81. American College of Gastroenterology. What everybody should know about inflammatory bowel disease www.acg.gi.org/patients/pdfs/ CommonGIProblems2.pdf (Accessed 19 May 2011)
82. Crohns and Colitis Foundation of America. Diet and nutrition www.ccfa.org/info/diet (Accessed 19 May 2011)
83. NIH. National Digestive Diseases Information Clearinghouse. Crohns Disease, NIH Publication No. 06-3410, February 2006 http://digestive.niddk.nih. gov/ddiseases/ pubs/crohns (Accessed 19 May 2011)
84. NIH. Medline Plus. Crohns Disease www.nlm.nih.gov/medlineplus/ency/ article/000249.htm (Accessed 19 May 2011)
85. NIH. Medline Plus. Ulcerative Colitis www.nlm.nih.gov/medlineplus/ency/ article/000250.htm (Accessed 19 May 2011)